The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 18,842 | 1,529,402 | SH | SOLE | 1,529,402 | 0 | 0 | ||
AC IMMUNE SA | COM | 99P1VHX22 | 354 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 1,007 | 71,500 | SH | SOLE | 71,500 | 0 | 0 | ||
ACLARIS THERAPEU | COM | 00461U105 | 2,692 | 192,835 | SH | SOLE | 192,835 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 25,052 | 554,000 | SH | SOLE | 554,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 4,244 | 167,500 | SH | SOLE | 167,500 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | 2,180 | 61,926 | SH | SOLE | 61,926 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 99P19TV23 | 340 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
BCLS ACQUISITION CORP- CL A | COM CL A | G0904B105 | 8,347 | 843,122 | SH | SOLE | 843,122 | 0 | 0 | ||
BELLUS HEALTH INC | COM NEW | 07987C204 | 7,540 | 816,000 | SH | SOLE | 816,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 7,204 | 267,195 | SH | SOLE | 267,195 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 1,300 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,388 | 303,396 | SH | SOLE | 303,396 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 2,428 | 243,250 | SH | SOLE | 243,250 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 268 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | ||
HEALTH SCIENCES ACQUISITIONS | ORD SHS | G4411D109 | 3,909 | 392,500 | SH | SOLE | 392,500 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | SHS | G46188101 | 2,862 | 35,888 | SH | SOLE | 35,888 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,704 | 154,356 | SH | SOLE | 154,356 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 1,277 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 5,422 | 563,607 | SH | SOLE | 563,607 | 0 | 0 | ||
JIYA ACQUISITION CORP -CL A | COM CL A | 47760M102 | 5,552 | 562,500 | SH | SOLE | 562,500 | 0 | 0 | ||
KURA ONCOLOGY INC. COMMON STOCK | COM | 50127T109 | 9,834 | 536,500 | SH | SOLE | 536,500 | 0 | 0 | ||
MERUS BV | COM | N5749R100 | 3,487 | 154,000 | SH | SOLE | 154,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 2,812 | 457,200 | SH | SOLE | 457,200 | 0 | 0 | ||
MIRATI THERAPEUTICS | COM | 60468T105 | 6,344 | 94,500 | SH | SOLE | 94,500 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 25 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 53 | 13,171 | SH | SOLE | 13,171 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,173 | 152,500 | SH | SOLE | 152,500 | 0 | 0 | ||
PRECISION BIOSCIENCES INC | COM | 74019P108 | 3,281 | 2,050,359 | SH | SOLE | 2,050,359 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 1,535 | 645,149 | SH | SOLE | 645,149 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 6,694 | 352,500 | SH | SOLE | 352,500 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 2,084 | 645,136 | SH | SOLE | 645,136 | 0 | 0 | ||
ROCHE GS | COM | 993960LE1 | 5,338 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 123 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,944 | 205,003 | SH | SOLE | 205,003 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 98 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 3,063 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 1,492 | 122,000 | SH | SOLE | 122,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 232 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 2,708 | 234,026 | SH | SOLE | 234,026 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 9,998 | 11,361,451 | SH | SOLE | 11,361,451 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 8,289 | 272,500 | SH | SOLE | 272,500 | 0 | 0 |